User profiles for Nesrin Mogulkoc

Nesrin Mogulkoc

Professor
Verified email at ege.edu.tr
Cited by 2999

Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease

MI Burgess, N Mogulkoc, RJ Bright-Thomas… - Journal of the American …, 2002 - Elsevier
Right ventricular (RV) dysfunction determines prognosis in patients with chronic pulmonary
disease. We examined the relative prognostic potential of measures of systolic, diastolic, and …

Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation

N Mogulkoc, MH Brutsche, PW Bishop… - American Journal of …, 2001 - atsjournals.org
Of patients awaiting lung transplantation, the death rates are highest in those with idiopathic
pulmonary fibrosis (IPF), suggesting that many IPF patients are referred late for …

Intracardiac thrombus in Behçet's disease: a systematic review

N Mogulkoc, MI Burgess, PW Bishop - Chest, 2000 - Elsevier
Background Intracardiac thrombus formation is a rare but serious complication of Behçet's
disease. We aimed to review the clinical and pathologic correlates of cardiac thrombus …

Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation

N Mogulkoc, A Veral, PW Bishop, U Bayindir… - Chest, 1999 - Elsevier
We describe two patients with histologically proven pulmonary Langerhans’ cell histiocytosis
in whom radiologic improvement occurred following smoking cessation. The patients had …

Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneumoniae Infection

N Mogulkoc, S Karakurt, B Isalska… - American journal of …, 1999 - atsjournals.org
In order to investigate the role of bacteria, including Mycoplasma pneumoniae and especially
Chlamydia pneumoniae in acute purulent exacerbations of chronic obstructive pulmonary …

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

…, AM Keogh, H Leuchte, N Mogulkoc… - The Lancet …, 2019 - thelancet.com
Background Idiopathic interstitial pneumonias are often complicated by pulmonary hypertension,
increasing morbidity and mortality. There are no approved treatments for pulmonary …

Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis

…, IE Fernandez, J Behr, N Mogulkoc… - American journal of …, 2019 - atsjournals.org
Rationale: Several common and rare genetic variants have been associated with idiopathic
pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: …

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

…, JC Grutters, C Valenzuela, N Mogulkoc… - The Lancet …, 2017 - thelancet.com
Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of complex
cause. Gastro-oesophageal reflux (GER) and microaspiration have been proposed as risk …

[HTML][HTML] The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis

T Tran, M Šterclová, N Mogulkoc, K Lewandowska… - Respiratory …, 2020 - Springer
Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established
to better understand its natural history, though their size and duration of follow-up are limited. …

[HTML][HTML] The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients

D Ozol, T Aysan, ZA Solak, N Mogulkoc, A Veral… - Respiratory …, 2005 - Elsevier
Chronic obstructive pulmonary disease (COPD) is characterised by a chronic inflammatory
process in the large and small airways, as well as in the lung parenchyma. Although the role …